Qube Research & Technologies LTD Collegium Pharmaceutical, Inc Transaction History

Qube Research & Technologies LTD

$62.3 Billion
Q2 2024

A detailed history of Qube Research & Technologies LTD transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 54,456 shares of COLL stock, worth $2.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

54,456

Holding current value

$2.12 Million

% of portfolio

0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$31.36 - $39.99 $1.71 Million - $2.18 Million	54,456 New	54,456 $1.75 Million
Q4 2023 Feb 13, 2024	SELL	$21.16 - $30.8 $2.35 Million - $3.42 Million	-111,009 Reduced 87.4%	16,001 $492,000
Q3 2023 Nov 13, 2023	BUY	$21.23 - $24.28 $2.36 Million - $2.7 Million	111,394 Added 713.33%	127,010 $2.84 Million
Q2 2023 Aug 14, 2023	SELL	$21.06 - $24.0 $407,468 - $464,352	-19,348 Reduced 55.34%	15,616 $335,000
Q1 2023 May 15, 2023	BUY	$23.0 - $29.88 $804,172 - $1.04 Million	34,964 New	34,964 $838,000
Q2 2022 Aug 15, 2022	SELL	$14.22 - $20.88 $280,119 - $411,315	-19,699 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$17.2 - $22.5 $1.07 Million - $1.4 Million	-62,177 Reduced 75.94%	19,699 $401,000
Q4 2021 Feb 01, 2022	BUY	$17.5 - $21.35 $972,667 - $1.19 Million	55,581 Added 211.37%	81,876 $1.53 Million
Q3 2021 Nov 12, 2021	BUY	$17.75 - $25.39 $146,970 - $210,229	8,280 Added 45.96%	26,295 $519,000
Q2 2021 Aug 13, 2021	SELL	$21.74 - $25.28 $40,088 - $46,616	-1,844 Reduced 9.29%	18,015 $426,000
Q1 2021 May 14, 2021	SELL	$19.25 - $26.1 $98,098 - $133,005	-5,096 Reduced 20.42%	19,859 $471,000
Q4 2020 Feb 16, 2021	BUY	$17.83 - $22.29 $444,947 - $556,246	24,955 New	24,955 $500,000
Q1 2020 May 15, 2020	SELL	$13.89 - $25.45 $273,744 - $501,568	-19,708 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$10.7 - $22.24 $210,875 - $438,305	19,708 New	19,708 $406,000

Others Institutions Holding COLL

# of Institutions

236

Shares Held

39.4M

Call Options Held

84.2K

Put Options Held

18.6K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.33B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Collegium Pharmaceutical, Inc Transaction History